New

Overactive Bladder Treatment Market

2021

Overactive Bladder Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, Intravesical Instillation); Disease Type (Idiopathic Overactive Bladder, Neurogenic Overactive Bladder) and Geography

| Report Code: TIPRE00004082 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Overactive Bladder Treatment Market 2028 By Pharmacotherapy, Disease Type and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



  • veractive bladder, commonly known as OAB, is characterised by a strong desire to urinate that is difficult to control. When the bladder muscles contract involuntarily, even when the volume of urine in the bladder is low, this is known as overactive bladder. The need to urinate is increased by these involuntary contractions. One may feel the desire to pass urine frequently throughout the day and night, as well as experience unintentional urine loss (urgency incontinence). Overactive bladder treatment consist of use of several agents to manage symptoms.

    MARKET SCOPE



    The

    "Global Overactive Bladder Treatment Market Analysis to 2028"

    is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the overactive bladder treatment market with detailed market segmentation by pharmacotherapy and disease type. The report provides key statistics on the market status of the leading overactive bladder treatment market players and offers key trends and opportunities in the market.

    MARKET SEGMENTATION



    • Based on pharmacotherapy the market is segmented as, anticholinergics, mirabegron, botox, neurostimulation and intravesical instillation.
    • Based on disease type the market is segmented as, Idiopathic Overactive Bladder and Neurogenic Overactive Bladder.

    MARKET DYNAMICS


    Drivers:



    • Increasing geriatric population, rising prevalence of overactive bladder disorders and urinary incotience disorders.
    • Increasing number of novel product launches as drug companies are developing therapies for management of such conditions.
    • Rising approvals of generic candidates.
    • Rising awareness about treatment of OAB is also expected to spur the market growth.

    Restraints:



    • However, risk of side effects from treatment is likley to restrain market growth.

    REGIONAL FRAMEWORK



    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The overactive bladder treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

    The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the overactive bladder treatment market in these regions.

    IMPACT OF COVID-19 ON OVERACTIVE BLADDER TREATMENT MARKET



    COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

    MARKET PLAYERS



    The report covers key developments in the overactive bladder treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from overactive bladder treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for overactive bladder treatment in the global market.

    The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the overactive bladder treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    • Astellas Pharma Inc
    • Pfizer, Inc
    • Teva Pharmaceutical Industries Ltd
    • ALLERGAN(Abbvie)
    • Mylan N.V(Viatris)
    • Hisamitsu Pharmaceutical Co.,Inc
    • Sanofi
    • Intas Pharmaceuticals Ltd.
    • Aurobindo Pharma Limited
    • Laborie, Inc
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Overactive Bladder Treatment Market - By Pharmacotherapy
    1.3.2 Overactive Bladder Treatment Market - By Disease Type
    1.3.3 Overactive Bladder Treatment Market - By Region
    1.3.3.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. OVERACTIVE BLADDER TREATMENT MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. OVERACTIVE BLADDER TREATMENT MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. OVERACTIVE BLADDER TREATMENT MARKET - GLOBAL MARKET ANALYSIS
    6.1. OVERACTIVE BLADDER TREATMENT - GLOBAL MARKET OVERVIEW
    6.2. OVERACTIVE BLADDER TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. OVERACTIVE BLADDER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - PHARMACOTHERAPY
    7.1. OVERVIEW
    7.2. PHARMACOTHERAPY MARKET FORECASTS AND ANALYSIS
    7.3. ANTICHOLINERGICS
    7.3.1. Overview
    7.3.2. Anticholinergics Market Forecast and Analysis
    7.3.3. Solifenacin Market
    7.3.3.1. Overview
    7.3.3.2. Solifenacin Market Forecast and Analysis
    7.3.4. Oxybutynin Market
    7.3.4.1. Overview
    7.3.4.2. Oxybutynin Market Forecast and Analysis
    7.3.5. Fesoterodine Market
    7.3.5.1. Overview
    7.3.5.2. Fesoterodine Market Forecast and Analysis
    7.3.6. Darifenacin Market
    7.3.6.1. Overview
    7.3.6.2. Darifenacin Market Forecast and Analysis
    7.3.7. Tolterodine Market
    7.3.7.1. Overview
    7.3.7.2. Tolterodine Market Forecast and Analysis
    7.3.8. Trospium Market
    7.3.8.1. Overview
    7.3.8.2. Trospium Market Forecast and Analysis
    7.3.9. Others Market
    7.3.9.1. Overview
    7.3.9.2. Others Market Forecast and Analysis
    7.4. MIRABEGRON
    7.4.1. Overview
    7.4.2. Mirabegron Market Forecast and Analysis
    7.5. BOTOX
    7.5.1. Overview
    7.5.2. Botox Market Forecast and Analysis
    7.6. NEUROSTIMULATION
    7.6.1. Overview
    7.6.2. Neurostimulation Market Forecast and Analysis
    7.7. INTRAVESICAL INSTILLATION
    7.7.1. Overview
    7.7.2. Intravesical Instillation Market Forecast and Analysis
    8. OVERACTIVE BLADDER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
    8.1. OVERVIEW
    8.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
    8.3. IDIOPATHIC OVERACTIVE BLADDER
    8.3.1. Overview
    8.3.2. Idiopathic Overactive Bladder Market Forecast and Analysis
    8.4. NEUROGENIC OVERACTIVE BLADDER
    8.4.1. Overview
    8.4.2. Neurogenic Overactive Bladder Market Forecast and Analysis

    9. OVERACTIVE BLADDER TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    9.1. NORTH AMERICA
    9.1.1 North America Overactive Bladder Treatment Market Overview
    9.1.2 North America Overactive Bladder Treatment Market Forecasts and Analysis
    9.1.3 North America Overactive Bladder Treatment Market Forecasts and Analysis - By Pharmacotherapy
    9.1.4 North America Overactive Bladder Treatment Market Forecasts and Analysis - By Disease Type
    9.1.5 North America Overactive Bladder Treatment Market Forecasts and Analysis - By Countries
    9.1.5.1 United States Overactive Bladder Treatment Market
    9.1.5.1.1 United States Overactive Bladder Treatment Market by Pharmacotherapy
    9.1.5.1.2 United States Overactive Bladder Treatment Market by Disease Type
    9.1.5.2 Canada Overactive Bladder Treatment Market
    9.1.5.2.1 Canada Overactive Bladder Treatment Market by Pharmacotherapy
    9.1.5.2.2 Canada Overactive Bladder Treatment Market by Disease Type
    9.1.5.3 Mexico Overactive Bladder Treatment Market
    9.1.5.3.1 Mexico Overactive Bladder Treatment Market by Pharmacotherapy
    9.1.5.3.2 Mexico Overactive Bladder Treatment Market by Disease Type
    9.2. EUROPE
    9.2.1 Europe Overactive Bladder Treatment Market Overview
    9.2.2 Europe Overactive Bladder Treatment Market Forecasts and Analysis
    9.2.3 Europe Overactive Bladder Treatment Market Forecasts and Analysis - By Pharmacotherapy
    9.2.4 Europe Overactive Bladder Treatment Market Forecasts and Analysis - By Disease Type
    9.2.5 Europe Overactive Bladder Treatment Market Forecasts and Analysis - By Countries
    9.2.5.1 Germany Overactive Bladder Treatment Market
    9.2.5.1.1 Germany Overactive Bladder Treatment Market by Pharmacotherapy
    9.2.5.1.2 Germany Overactive Bladder Treatment Market by Disease Type
    9.2.5.2 France Overactive Bladder Treatment Market
    9.2.5.2.1 France Overactive Bladder Treatment Market by Pharmacotherapy
    9.2.5.2.2 France Overactive Bladder Treatment Market by Disease Type
    9.2.5.3 Italy Overactive Bladder Treatment Market
    9.2.5.3.1 Italy Overactive Bladder Treatment Market by Pharmacotherapy
    9.2.5.3.2 Italy Overactive Bladder Treatment Market by Disease Type
    9.2.5.4 Spain Overactive Bladder Treatment Market
    9.2.5.4.1 Spain Overactive Bladder Treatment Market by Pharmacotherapy
    9.2.5.4.2 Spain Overactive Bladder Treatment Market by Disease Type
    9.2.5.5 United Kingdom Overactive Bladder Treatment Market
    9.2.5.5.1 United Kingdom Overactive Bladder Treatment Market by Pharmacotherapy
    9.2.5.5.2 United Kingdom Overactive Bladder Treatment Market by Disease Type
    9.2.5.6 Rest of Europe Overactive Bladder Treatment Market
    9.2.5.6.1 Rest of Europe Overactive Bladder Treatment Market by Pharmacotherapy
    9.2.5.6.2 Rest of Europe Overactive Bladder Treatment Market by Disease Type
    9.3. ASIA-PACIFIC
    9.3.1 Asia-Pacific Overactive Bladder Treatment Market Overview
    9.3.2 Asia-Pacific Overactive Bladder Treatment Market Forecasts and Analysis
    9.3.3 Asia-Pacific Overactive Bladder Treatment Market Forecasts and Analysis - By Pharmacotherapy
    9.3.4 Asia-Pacific Overactive Bladder Treatment Market Forecasts and Analysis - By Disease Type
    9.3.5 Asia-Pacific Overactive Bladder Treatment Market Forecasts and Analysis - By Countries
    9.3.5.1 Australia Overactive Bladder Treatment Market
    9.3.5.1.1 Australia Overactive Bladder Treatment Market by Pharmacotherapy
    9.3.5.1.2 Australia Overactive Bladder Treatment Market by Disease Type
    9.3.5.2 China Overactive Bladder Treatment Market
    9.3.5.2.1 China Overactive Bladder Treatment Market by Pharmacotherapy
    9.3.5.2.2 China Overactive Bladder Treatment Market by Disease Type
    9.3.5.3 India Overactive Bladder Treatment Market
    9.3.5.3.1 India Overactive Bladder Treatment Market by Pharmacotherapy
    9.3.5.3.2 India Overactive Bladder Treatment Market by Disease Type
    9.3.5.4 Japan Overactive Bladder Treatment Market
    9.3.5.4.1 Japan Overactive Bladder Treatment Market by Pharmacotherapy
    9.3.5.4.2 Japan Overactive Bladder Treatment Market by Disease Type
    9.3.5.5 South Korea Overactive Bladder Treatment Market
    9.3.5.5.1 South Korea Overactive Bladder Treatment Market by Pharmacotherapy
    9.3.5.5.2 South Korea Overactive Bladder Treatment Market by Disease Type
    9.3.5.6 Rest of Asia-Pacific Overactive Bladder Treatment Market
    9.3.5.6.1 Rest of Asia-Pacific Overactive Bladder Treatment Market by Pharmacotherapy
    9.3.5.6.2 Rest of Asia-Pacific Overactive Bladder Treatment Market by Disease Type
    9.4. MIDDLE EAST AND AFRICA
    9.4.1 Middle East and Africa Overactive Bladder Treatment Market Overview
    9.4.2 Middle East and Africa Overactive Bladder Treatment Market Forecasts and Analysis
    9.4.3 Middle East and Africa Overactive Bladder Treatment Market Forecasts and Analysis - By Pharmacotherapy
    9.4.4 Middle East and Africa Overactive Bladder Treatment Market Forecasts and Analysis - By Disease Type
    9.4.5 Middle East and Africa Overactive Bladder Treatment Market Forecasts and Analysis - By Countries
    9.4.5.1 South Africa Overactive Bladder Treatment Market
    9.4.5.1.1 South Africa Overactive Bladder Treatment Market by Pharmacotherapy
    9.4.5.1.2 South Africa Overactive Bladder Treatment Market by Disease Type
    9.4.5.2 Saudi Arabia Overactive Bladder Treatment Market
    9.4.5.2.1 Saudi Arabia Overactive Bladder Treatment Market by Pharmacotherapy
    9.4.5.2.2 Saudi Arabia Overactive Bladder Treatment Market by Disease Type
    9.4.5.3 U.A.E Overactive Bladder Treatment Market
    9.4.5.3.1 U.A.E Overactive Bladder Treatment Market by Pharmacotherapy
    9.4.5.3.2 U.A.E Overactive Bladder Treatment Market by Disease Type
    9.4.5.4 Rest of Middle East and Africa Overactive Bladder Treatment Market
    9.4.5.4.1 Rest of Middle East and Africa Overactive Bladder Treatment Market by Pharmacotherapy
    9.4.5.4.2 Rest of Middle East and Africa Overactive Bladder Treatment Market by Disease Type
    9.5. SOUTH AND CENTRAL AMERICA
    9.5.1 South and Central America Overactive Bladder Treatment Market Overview
    9.5.2 South and Central America Overactive Bladder Treatment Market Forecasts and Analysis
    9.5.3 South and Central America Overactive Bladder Treatment Market Forecasts and Analysis - By Pharmacotherapy
    9.5.4 South and Central America Overactive Bladder Treatment Market Forecasts and Analysis - By Disease Type
    9.5.5 South and Central America Overactive Bladder Treatment Market Forecasts and Analysis - By Countries
    9.5.5.1 Brazil Overactive Bladder Treatment Market
    9.5.5.1.1 Brazil Overactive Bladder Treatment Market by Pharmacotherapy
    9.5.5.1.2 Brazil Overactive Bladder Treatment Market by Disease Type
    9.5.5.2 Argentina Overactive Bladder Treatment Market
    9.5.5.2.1 Argentina Overactive Bladder Treatment Market by Pharmacotherapy
    9.5.5.2.2 Argentina Overactive Bladder Treatment Market by Disease Type
    9.5.5.3 Rest of South and Central America Overactive Bladder Treatment Market
    9.5.5.3.1 Rest of South and Central America Overactive Bladder Treatment Market by Pharmacotherapy
    9.5.5.3.2 Rest of South and Central America Overactive Bladder Treatment Market by Disease Type

    10. INDUSTRY LANDSCAPE
    10.1. MERGERS AND ACQUISITIONS
    10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    10.3. NEW PRODUCT LAUNCHES
    10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    11. OVERACTIVE BLADDER TREATMENT MARKET, KEY COMPANY PROFILES
    11.1. ASTELLAS PHARMA INC
    11.1.1. Key Facts
    11.1.2. Business Description
    11.1.3. Products and Services
    11.1.4. Financial Overview
    11.1.5. SWOT Analysis
    11.1.6. Key Developments
    11.2. PFIZER, INC
    11.2.1. Key Facts
    11.2.2. Business Description
    11.2.3. Products and Services
    11.2.4. Financial Overview
    11.2.5. SWOT Analysis
    11.2.6. Key Developments
    11.3. TEVA PHARMACEUTICAL INDUSTRIES LTD
    11.3.1. Key Facts
    11.3.2. Business Description
    11.3.3. Products and Services
    11.3.4. Financial Overview
    11.3.5. SWOT Analysis
    11.3.6. Key Developments
    11.4. ALLERGAN( ABBVIE)
    11.4.1. Key Facts
    11.4.2. Business Description
    11.4.3. Products and Services
    11.4.4. Financial Overview
    11.4.5. SWOT Analysis
    11.4.6. Key Developments
    11.5. MYLAN N.V( VIATRIS)
    11.5.1. Key Facts
    11.5.2. Business Description
    11.5.3. Products and Services
    11.5.4. Financial Overview
    11.5.5. SWOT Analysis
    11.5.6. Key Developments
    11.6. HISAMITSU PHARMACEUTHISAMITSU PHARMACEUTICAL CO.,INCICAL CO.,INC
    11.6.1. Key Facts
    11.6.2. Business Description
    11.6.3. Products and Services
    11.6.4. Financial Overview
    11.6.5. SWOT Analysis
    11.6.6. Key Developments
    11.7. SANOFI
    11.7.1. Key Facts
    11.7.2. Business Description
    11.7.3. Products and Services
    11.7.4. Financial Overview
    11.7.5. SWOT Analysis
    11.7.6. Key Developments
    11.8. INTAS PHARMACEUTICALS LTD.
    11.8.1. Key Facts
    11.8.2. Business Description
    11.8.3. Products and Services
    11.8.4. Financial Overview
    11.8.5. SWOT Analysis
    11.8.6. Key Developments
    11.9. AUROBINDO PHARMA LIMITED
    11.9.1. Key Facts
    11.9.2. Business Description
    11.9.3. Products and Services
    11.9.4. Financial Overview
    11.9.5. SWOT Analysis
    11.9.6. Key Developments
    11.10. LABORIE, INC
    11.10.1. Key Facts
    11.10.2. Business Description
    11.10.3. Products and Services
    11.10.4. Financial Overview
    11.10.5. SWOT Analysis
    11.10.6. Key Developments

    12. APPENDIX
    12.1. ABOUT THE INSIGHT PARTNERS
    12.2. GLOSSARY OF TERMS
    The List of Companies

    1. Astellas Pharma Inc
    2. Pfizer, Inc
    3. Teva Pharmaceutical Industries Ltd
    4. ALLERGAN(Abbvie)
    5. Mylan N.V(Viatris)
    6. Hisamitsu PharmaceutHisamitsu Pharmaceutical Co.,Incical Co.,Inc
    7. Sanofi
    8. Intas Pharmaceuticals Ltd.
    9. Aurobindo Pharma Limited
    10. Laborie, Inc
    TIPRE00004082
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Request for Sample
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.